High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis

Frontiers in Public Health

Lan Chen¹ 

关键词: erythropoiesis-stimulating agent;    chronic kidney disease;    hemodialysis;    hemoglobin;    parathyroid hormone;   

DOI  :  10.3389/fpubh.2015.00258

学科分类：卫生学

来源: Frontiers

【 摘 要 】

ObjectiveAnemia and secondary hyperparathyroidism are the two most common complications associated with chronic kidney disease. Erythropoiesis-stimulating agents (ESAs) are widely used in the management of anemia in hemodialysis patients. A reverse correlation has been established between hyperparathyroidism and hemoglobin levels. The aim of this retrospective study is to evaluate the relationship of high-dose ESAs and hyperparathyroidism in hemodialysis patients with anemia.

【 授权许可】

CC BY